{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-037452","form_type":"8-K","ticker":"ODYS","cik":"0001577445","company_name":"Odysight.ai Inc.","filed_at":"2023-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.610475+00:00","generated_at":"2026-06-09T22:38:21.455032+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Odysight.ai receives $3.3M purchase order from Fortune 500 medical partner for FY2024","bullets":["Expanded PO from Fortune 500 orthopaedic company totals $3.3M for fiscal year 2024.","Visual technology integrated into partner's FDA-approved minimally invasive surgical device.","Builds on prior January 2023 announcement; company expects substantial future growth.","CEO Yehu Ofer: trusted by Fortune 500 in critical medical technology field."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-037452","json":"https://secwatch.observer/filing/0001493152-23-037452.json","markdown":"https://secwatch.observer/filing/0001493152-23-037452.md","text":"https://secwatch.observer/filing/0001493152-23-037452.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1577445/000149315223037452/0001493152-23-037452-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1577445/000149315223037452/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T22:38:21.455032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}